We have some exciting news to share! The Motley Fool UK has now become The Twelfth Magpie -- an independent, UK-owned company, led by our long-serving UK management team — Mark Rogers, Chris Nials and Heather Adlington. In practical terms, it’s the same team you know, now fully focused on serving our UK readers and members.

Just as importantly, our approach remains unchanged: long-term, jargon-free, and on your side. This site is our new home, and there will be extra tweaks made across the coming few days as we settle in. So if anything looks a little off, please bear with us!

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

2 FTSE 250 investment trusts I’d buy and hold for 20 years

These unfashionable, value-focused investment trusts could deliver superior returns in the coming decades, says G A Chester.

| More on:

You’re reading a free article with opinions that may differ from The Twelfth Magpie’s Premium Investing Services. Become a member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn more, and get a free 'Best Buy Now' stock!.

The great financial experiment of the last 10 years has seen investors flock to growth and momentum. It’s been the era of the so-called FAANGs and ‘bond proxy’ stocks.

The FAANGs are Facebook, Amazon, Apple, Netflix and Google’s parent Alphabet. Bond proxies are blue-chip companies that pay reliable, bond-coupon-like dividends. Think Procter & Gamble and Johnson & Johnson in the US, and Unilever and Diageo in the UK.

Should you buy Avi Global Trust Plc shares today?

Before you decide, please take a moment to review this report first. Despite ongoing uncertainties from US tariffs to global conflicts, Mark Rogers and his team believe many UK shares still trade at substantial discounts, offering savvy investors plenty of potential opportunities to learn about.

That’s why this could be an ideal time to secure this valuable research – Mark’s analysts have scoured the markets to reveal 5 of his favourite long-term ‘Buys’. Please, don’t make any big decisions before seeing them.

These themes are reflected in the portfolios of London’s current best-performing investment trusts in the global sector: Scottish Mortgage (a 10-year return of 609%) and Lindsell Train (625%).

However, as almost all investment literature warns, “past performance may not be indicative of future results”. And I’m concerned this could well be the case with the likes of Scottish Mortgage. This is due to the eye-watering valuations of many of the underlying holdings.

Unfashionable

Value investing, as formulated by Ben Graham aeons ago, has outperformed growth over long timescales. As such, I believe unfashionable, value-focused investment trusts could deliver superior returns in the coming decades.

With this in mind, I’d be happy to buy FTSE 250-listed AVI Global Trust (LSE: AGT) and Caledonia Investments (LSE: CLDN). Their returns over the last 10 years — 130% and 157%, respectively — have been solid rather than spectacular.

Discount-to-NAV specialist

AVI Global (formerly British Empire Trust) was established in 1889, and has been managed by Asset Value Investors since 1985. This trust seeks out listed companies whose shares stand at compelling discounts to their estimated underlying net asset values (NAVs). It looks for attractive businesses, with honest, intelligent management willing to engage with shareholders, and catalysts to bring the share prices to their true values.

It trawls the world for opportunities. For example, it invested in 16 Japanese companies with substantial excess capital, and is engaging with management about releasing it. The trust’s other investments include discounted closed-end investment companies (such as Third Point Offshore), asset-backed groups (such as Sony Corp) and family-backed holding companies (such as Jardine Strategic).

AVI Global reckons its portfolio is at a discount of over 30% to underlying NAV. And with the trust itself trading at a discount of around 10%, I see good value on offer for investors today.

Long-term value investor

Caledonia’s heritage goes back to the shipping empire established by Sir Charles Cayzer in 1878. The trust still enjoys the backing of the Cayzer family today. It says this gives “support to our long-term value investment horizon and provides a foundation to our culture of conservative generational wealth management.”

Over a third of Caledonia’s net assets are private capital investments in 11 UK companies with equity values of £25m-£125m. It has significant direct influence over these businesses and their management. They include control systems firm Deep Sea Electronics and bingo clubs chain Buzz Bingo.

The trust also invests in quoted companies (such as Microsoft and British American Tobacco) and funds, including quoted and private equity. The funds provide broad exposure to areas of the world where it would prove more difficult for Caledonia to invest directly.

Trading at a 17% discount to NAV, I reckon this trust is another terrific pick for long-term value investors.

G A Chester has no position in any of the shares mentioned. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool’s board of directors. Randi Zuckerberg, a former director of market development and spokeswoman for Facebook and sister to its CEO, Mark Zuckerberg, is a member of The Motley Fool's board of directors. The Motley Fool UK owns shares of and has recommended Alphabet (A shares), Alphabet (C shares), Apple, Facebook, Microsoft, and Unilever. The Motley Fool UK has recommended Diageo and Johnson & Johnson and recommends the following options: long January 2021 $85 calls on Microsoft and short January 2021 $115 calls on Microsoft. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

A row of satellite radars at night
Investing Articles

This ex-penny stock has crushed Rolls-Royce shares over 5 years! Is there more to come?

With all eyes on Rolls-Royce shares, this growth share with a connection to SpaceX might have gone unnoticed by a…

Read more »

Close-up as a woman counts out modern British banknotes.
Investing Articles

With a 6.4% yield and P/E of 10 is this FTSE dividend stock a hidden passive income gem?

Building a portfolio of solid UK dividend stocks isn't hard. Paul Summers takes a closer look at one high-yielding candidate…

Read more »

Black woman using smartphone at home, watching stock charts.
Growth Shares

At 112p, where next for the Lloyds share price? 168p or 56p?

Jon Smith mulls over the direction going forward for the Lloyds share price, and explains why two very different scenarios…

Read more »

Investing Articles

This dividend stock has a 7.3% yield, and Stocks and Shares ISA investors are buying!

Looking to move from a Cash ISA to a Stocks and Shares ISA to target passive income? Alan Oscroft has…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

Could Rolls-Royce shares lock in another 34% gain before Christmas?

Mark Hartley takes a look at some of the more optimistic price targets for Rolls-Royce, and considers a best-case scenario.…

Read more »

This way, That way, The other way - pointing in different directions
Investing Articles

Investec vs Aberdeen: which is the better income stock to buy?

Aiming to boost the average yield of his income portfolio, Mark Hartley's looking for new income stocks to buy on…

Read more »

Asian man looking concerned while studying paperwork at his desk in an office
Investing Articles

Down 41% since January, this quality S&P 500 stock is stinking out my ISA

The tide's turned against this S&P 500 robotics stock. Is it time to dump it? Or is there a no-brainer…

Read more »

GSK scientist holding lab syringe
Investing Articles

By mid-2027, analysts expect £6,000 in GSK shares to be worth…

GSK shares are currently trading almost 20% below their 2026 highs. Is there potential for a rebound over the next…

Read more »